Suppr超能文献

马来西亚奥密克戎浪潮后成年人的新冠后状况:一项前瞻性队列研究。

Post COVID-19 condition among adults in Malaysia following the Omicron wave: A prospective cohort study.

机构信息

Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.

Hospital Sultanah Bahiyah, Ministry of Health Malaysia, Alor Setar, Kedah, Malaysia.

出版信息

PLoS One. 2024 Jan 5;19(1):e0296488. doi: 10.1371/journal.pone.0296488. eCollection 2024.

Abstract

Post COVID-19 condition is an important public health problem as we emerge from the COVID-19 pandemic. In this prospective cohort study, we aimed to determine the prevalence of this condition and assess its associated factors and impact on health-related quality of life in a population setting in Malaysia. Study was conducted from April to June 2022 when the Omicron variant predominated. All individuals testing positive for SARS-CoV-2 infection (RT-PCR, RTK-Ag) were invited for participation. Study questionnaires were delivered via the MySejahtera platform (mobile application). From the total of 44,386 participants who provided responses up to 3-months interval, 1,510 participants (3.4%) fulfilled the post COVID-19 condition criteria. Majority of the affected participants (83.8%, n = 1,265) experienced either cough, fatigue or forgetfulness-the three most common symptoms. Being females, having existing comorbidities, presence of symptoms and requiring hospital admission during the acute illness were associated with higher likelihoods of developing the post COVID-19 condition at 3-months interval. Amongst the 1,510 individuals, one in five had limitations in performing their usual daily activities while at least one in three expressed that their work was affected. Understanding this condition better is essential to guide strategic and responsive plans of action, which may require coordinated multidisciplinary interventions.

摘要

新冠后状况是我们走出新冠疫情后面临的一个重要公共卫生问题。在这项前瞻性队列研究中,我们旨在确定这种状况的流行率,并评估其相关因素及其对马来西亚人群健康相关生活质量的影响。研究于 2022 年 4 月至 6 月奥密克戎变异株占主导地位期间进行。所有 SARS-CoV-2 感染检测呈阳性的个体(RT-PCR、RTK-Ag)均被邀请参加。研究问卷通过 MySejahtera 平台(移动应用程序)提供。在截至 3 个月间隔提供回复的总计 44,386 名参与者中,有 1,510 名参与者(3.4%)符合新冠后状况标准。大多数受影响的参与者(83.8%,n=1,265)经历了三种最常见的症状,即咳嗽、疲劳或健忘。女性、存在合并症、在急性疾病期间出现症状和需要住院治疗与 3 个月间隔后发生新冠后状况的可能性更高相关。在 1,510 名个体中,五分之一的人在进行日常活动时存在障碍,至少有三分之一的人表示他们的工作受到了影响。更好地了解这种状况对于指导战略和响应性行动计划至关重要,这可能需要协调多学科干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb9a/10769055/6083fe8a161d/pone.0296488.g001.jpg

相似文献

1
Post COVID-19 condition among adults in Malaysia following the Omicron wave: A prospective cohort study.
PLoS One. 2024 Jan 5;19(1):e0296488. doi: 10.1371/journal.pone.0296488. eCollection 2024.
3
Evaluation of post-COVID symptoms of the SARS-CoV-2 Delta and Omicron variants in children: a prospective study.
Eur J Pediatr. 2023 Oct;182(10):4565-4571. doi: 10.1007/s00431-023-05134-6. Epub 2023 Aug 1.
7
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestations.
BMC Infect Dis. 2023 Oct 13;23(1):684. doi: 10.1186/s12879-023-08595-0.
9
Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
Turk Psikiyatri Derg. 2021 Fall;32(3):219-221. doi: 10.5080/u26175.

引用本文的文献

2
Global Prevalence of Long COVID, its Subtypes and Risk factors: An Updated Systematic Review and Meta-Analysis.
medRxiv. 2025 Jan 6:2025.01.01.24319384. doi: 10.1101/2025.01.01.24319384.
3
Nirmatrelvir/ritonavir treatment and the risk of post-COVID condition over 180 days in Malaysia.
BMC Infect Dis. 2024 Aug 5;24(1):780. doi: 10.1186/s12879-024-09679-1.
4
Post-COVID syndrome prevalence: a systematic review and meta-analysis.
BMC Public Health. 2024 Jul 4;24(1):1785. doi: 10.1186/s12889-024-19264-5.

本文引用的文献

1
Systematic Review of the Prevalence of Long COVID.
Open Forum Infect Dis. 2023 May 3;10(7):ofad233. doi: 10.1093/ofid/ofad233. eCollection 2023 Jul.
2
Long COVID: major findings, mechanisms and recommendations.
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
3
4
A new paradigm is needed to explain long COVID.
Lancet Respir Med. 2023 Feb;11(2):e12-e13. doi: 10.1016/S2213-2600(22)00501-X. Epub 2023 Jan 5.
5
The Epidemiology of Long Coronavirus Disease in US Adults.
Clin Infect Dis. 2023 May 3;76(9):1636-1645. doi: 10.1093/cid/ciac961.
6
Risk factors of post-COVID-19 conditions attributed to COVID-19 disease in people aged ≥50 years in Europe and Israel.
Public Health. 2023 Jan;214:69-72. doi: 10.1016/j.puhe.2022.09.017. Epub 2022 Sep 27.
7
Estimating the infection burden of COVID-19 in Malaysia.
PLoS Negl Trop Dis. 2022 Nov 8;16(11):e0010887. doi: 10.1371/journal.pntd.0010887. eCollection 2022 Nov.
9
Prevalence and Correlates of Long COVID Symptoms Among US Adults.
JAMA Netw Open. 2022 Oct 3;5(10):e2238804. doi: 10.1001/jamanetworkopen.2022.38804.
10
Long COVID following Omicron wave in Eastern India-A retrospective cohort study.
J Med Virol. 2023 Jan;95(1):e28214. doi: 10.1002/jmv.28214. Epub 2022 Oct 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验